Related Experiment Video
Updated: Jun 3, 2026
07:51
Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface
Published on: May 21, 2015
HLA-G and pregnancy adverse outcomes
Monia Cecati1, Stefano R Giannubilo, Monica Emanuelli
1Dipartimento di Biochimica, Biologia e Genetica, Università Politecnica delle Marche, via Ranieri 65, Ancona 60131, Italy. moniacecati@interfree.it
Medical Hypotheses
|March 8, 2011
Summary
Human Leukocyte Antigen-G (HLA-G) plays a crucial role in pregnancy. Aberrant HLA-G expression and genetic variations in both mother and fetus are linked to pregnancy complications like preeclampsia and miscarriage.
Area of Science:
- Immunology
- Reproductive Biology
- Genetics
Background:
- Pregnancy complications like preeclampsia, recurrent pregnancy loss (RPL), IUGR, and premature birth are linked to immune interactions at the fetal-maternal interface.
- Human Leukocyte Antigen-G (HLA-G) is expressed on trophoblast cells invading the uterus, suggesting a role in immune tolerance.
- HLA-G has multiple isoforms (membrane-bound and soluble) and potential immunosuppressive functions.
Purpose of the Study:
- To investigate the association between HLA-G expression, genetic variations, and pregnancy complications.
- To highlight the importance of considering both maternal and fetal/placental genotypes in studies of pregnancy diseases.
Main Methods:
- Review of existing evidence on HLA-G expression and its isoforms (membrane-bound and soluble).
- Analysis of the link between HLA-G genetic variations (polymorphisms) and pregnancy outcomes.
- Emphasis on the need for studies examining both maternal and fetal/placental HLA-G contributions.
Main Results:
- Reduced or aberrant HLA-G expression is associated with pregnancy complications, including preeclampsia and miscarriage risk.
- HLA-G polymorphisms may further influence pregnancy outcomes.
- Current research often overlooks the fetal/placental contribution to HLA-G's role in pregnancy.
Conclusions:
- Both maternal and fetal/placental HLA-G expression and genetics are critical for successful pregnancy.
- Future studies on placental diseases must incorporate fetal/placental HLA-G analysis.
- Understanding HLA-G's role is key to managing immune-related pregnancy complications.
Related Concept Videos
01:19Rh Blood Group
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:22Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
01:15Transcytosis of IgG
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...